Introduction to head-to-head trials
Dr Keith Kerr (UK) and Dr Barbara Melosky (Canada) explain the benefits of conducting head-to-head trials in order to provide further information about the efficacy of available lung cancer treatments.
Dr Keith Kerr (UK) and Dr Barbara Melosky (Canada) explain the benefits of conducting head-to-head trials in order to provide further information about the efficacy of available lung cancer treatments.